Isotretinoin Liver Function Tests and Triglyceride Monitoring
FDA label sets no dose adjustment for hepatic impairment. Start 0.5 mg/kg/day, check LFTs baseline and every 4 weeks, stop if ALT/AST exceed 3x ULN.
Isotretinoin Pharmacogenomics: How Genetic Variability Shapes Accutane Response
A clinical deep-dive into how CYP450 polymorphisms, retinoid receptor variants, and lipid metabolism genes influence isotretinoin efficacy, side effects, and dosing.
Restarting Isotretinoin (Accutane) After Acute Illness: A Clinical Guide
When and how to safely restart isotretinoin after an acute illness, including dose adjustments, lab re-checks, iPLEDGE compliance, and signals that require a longer hold.
Switching From or To Isotretinoin (Accutane): Protocols, Timing, and Clinical Evidence
Evidence-based guide to switching from oral antibiotics, topical retinoids, or hormonal therapy to isotretinoin, and transitioning off isotretinoin to maintenance regimens.